Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Delivery”

242 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 242 results

Post-approval studies (Phase 4)Not Yet RecruitingNCT07624669
What this trial is testing

A First in Human Study Investigating the Safety of an Unloaded and Loaded (With a Tetanus-containing Vaccine Booster) Microneedle Patch in Healthy Adults

Who this might be right for
Vaccine DeliveryTetanus
Microneedle Solutions Ltd 30
Early research (Phase 1)Study completedNCT00199849
What this trial is testing

NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine

Who this might be right for
Prostate CancerBladder CancerNon-small Cell Lung Cancer+2 more
Ludwig Institute for Cancer Research 18
Early research (Phase 1)Study completedNCT03596801
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children

Who this might be right for
RSV Infection
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Ended earlyNCT02890381
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (RSV LID cp ΔM2-2) in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 17
Early research (Phase 1)Ended earlyNCT01493154
What this trial is testing

Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients

Who this might be right for
Head and Neck Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2
Testing effectiveness (Phase 2)WithdrawnNCT01110044
What this trial is testing

Study of a Birth Dose of GlaxoSmithKline Biologicals' 251154 Vaccine

Who this might be right for
Infections, Rotavirus
GlaxoSmithKline
Not applicableUnknownNCT01508507
What this trial is testing

Effectiveness of a Bivalent Killed Whole Cell Based Oral Cholera Vaccine

Who this might be right for
Cholera
International Vaccine Institute 240
Testing effectiveness (Phase 2)UnknownNCT00981695
What this trial is testing

Safety and Immunogenicity Study of Candidate HIV-1 Vaccine Given to Healthy Infants Born to HIV-1-infected Mothers

Who this might be right for
HIV-1HIV Infections
Medical Research Council 72
Early research (Phase 1)WithdrawnNCT02277392
What this trial is testing

A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal Cancer

Who this might be right for
Ovarian, Fallopian Tube and Peritoneal Cancer
Abramson Cancer Center at Penn Medicine
Early research (Phase 1)Study completedNCT03682107
What this trial is testing

Andes Virus DNA Vaccine for the Prevention of Hantavirus Pulmonary Syndrome Using the PharmaJet Stratis(R) Needle-Free Injection Delivery Device

Who this might be right for
Hantavirus Pulmonary InfectionImmunisation
National Institute of Allergy and Infectious Diseases (NIAID) 48
Early research (Phase 1)Study completedNCT02794870
What this trial is testing

Evaluating the Infectivity, Safety and Immunogenicity of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine in RSV-Seronegative Infants 6 to 24 Months of Age

Who this might be right for
Respiratory Syncytial Virus Infections
National Institute of Allergy and Infectious Diseases (NIAID) 33
Early research (Phase 1)Study completedNCT00002231
What this trial is testing

Safety and Effects of Giving a New HIV Vaccine (GENEVAX-HIV) to HIV-Negative Volunteers

Who this might be right for
HIV InfectionsHIV Seronegativity
Wyeth-Lederle Vaccines
Not applicableStudy completedNCT01767324
What this trial is testing

Site Selection for Intracutaneous Saline Delivery

Who this might be right for
Intracutaneous Drug Delivery
FluGen Inc 12
Not applicableEnded earlyNCT00138320
What this trial is testing

Herpevac Neonatal Substudy

Who this might be right for
Herpes Simplex
National Institute of Allergy and Infectious Diseases (NIAID) 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT01697527
What this trial is testing

Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies

Who this might be right for
Malignant Neoplasm
Jonsson Comprehensive Cancer Center 6
Early research (Phase 1)Study completedNCT02438423
What this trial is testing

Inactivated Influenza Vaccine Delivered by Microneedle Patch or by Hypodermic Needle

Who this might be right for
Influenza
Mark Prausnitz 100
Testing effectiveness (Phase 2)Study completedNCT00289796
What this trial is testing

Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib Vaccine

Who this might be right for
Hepatitis B
GlaxoSmithKline 121
Testing effectiveness (Phase 2)Study completedNCT00880698
What this trial is testing

Safety and Immune Response of a Rotavirus Vaccine in HIV-infected and Uninfected Children Born to HIV-infected Mothers

Who this might be right for
HIV InfectionRotavirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 202
Early research (Phase 1)Study completedNCT02775292
What this trial is testing

Gene-Modified T Cells, Vaccine Therapy, and Nivolumab in Treating Patients With Stage IV or Locally Advanced Solid Tumors Expressing NY-ESO-1

Who this might be right for
Adult Solid NeoplasmChildhood Solid NeoplasmMetastatic Neoplasm
Jonsson Comprehensive Cancer Center 1
Early research (Phase 1)Study completedNCT01859325
What this trial is testing

Therapeutic Vaccine for HIV

Who this might be right for
HIVTherapeutic Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 33
Load More Results